In-Vitro Diagnostics market is expected to reach US$ 160.68 billion by 2033 from US$ 97.56 billion in 2024, with a CAGR of 5.70% from 2025 to 2033. The main drivers propelling the in vitro diagnostics market share are the growing elderly population, the increasing prevalence of infectious diseases, the ongoing technology improvements, and the altering consumer preferences toward personalized medication.